Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-10 for Moderate-to-Severe Psoriasis
NCT00001797Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 1999
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human interleukin-10 in plaque psoriasis, sponsored by National Cancer Institute. Started Jan 1999; status: completed.
02
Drugs
recombinant human interleukin-10
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00001797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001797.